Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04418947 · ClinicalTrials.gov registry record · NA
Project Resurgence Communication Trial
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 11,120
- Enrollment target
NCT04418947: Completed NA study, sponsored by University of Pennsylvania.
NCT04418947 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 11,120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04418947, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,120 participants
- Enrollment target
Study Summary
Randomized, double-blind, of standard of care vs additional communication and factorial design of intervention letter vs. control letter and EHR vs mail delivery mechanism in patients who canceled visits and did not reschedule over a 90 day period starting March 9, 2020.
Interventions
- OTHER Communication type
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,120 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2020-07-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04418947
The ClinicalTrials.gov registry entry for NCT04418947 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11,120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Communication type is the first listed.
NCT04418947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04418947 about?
NCT04418947 is a clinical study titled "Project Resurgence Communication Trial". Randomized, double-blind, of standard of care vs additional communication and factorial design of intervention letter vs. control letter and EHR vs mail delivery mechanism in patients who canceled visits and did not reschedule over a 90 day period starting March 9, 2020.
What is the current status of trial NCT04418947?
This trial is currently completed. It is a NA study. The enrollment target is 11,120 participants. The study started on 2020-06-15. Estimated completion is 2020-07-17.
What interventions are being tested in trial NCT04418947?
The interventions under investigation include: Communication type (OTHER).
Who is sponsoring clinical trial NCT04418947?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.